Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-048367
Filing Date
2015-08-12
Accepted
2015-08-12 12:18:47
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v416244_10-q.htm 10-Q 586062
2 EXHIBIT 10.1 v416244_ex10-1.htm EX-10.1 44543
3 EXHIBIT 31.1 v416244_ex31-1.htm EX-31.1 9038
4 EXHIBIT 32.1 v416244_ex32-1.htm EX-32.1 4975
  Complete submission text file 0001144204-15-048367.txt   7138547

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prgb-20150630.xml EX-101.INS 1613328
6 XBRL TAXONOMY EXTENSION SCHEMA prgb-20150630.xsd EX-101.SCH 74158
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prgb-20150630_cal.xml EX-101.CAL 49768
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgb-20150630_def.xml EX-101.DEF 476420
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgb-20150630_lab.xml EX-101.LAB 528730
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgb-20150630_pre.xml EX-101.PRE 533184
Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26505
Business Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51474 | Film No.: 151046152
SIC: 2834 Pharmaceutical Preparations